Models for the marrow: A comprehensive review of AI‐based cell classification methods and malignancy detection in bone marrow aspirate smears
Open Access
- 3 December 2024
- journal article
- review article
- Published by Wiley in HemaSphere
- Vol. 8 (12) , e70048
Abstract
Given the high prevalence of artificial intelligence (AI) research in medicine, the development of deep learning (DL) algorithms based on image recognition, such as the analysis of bone marrow aspirate (BMA) smears, is rapidly increasing in the field of hematology and oncology. The models are trained to identify the optimal regions of the BMA smear for differential cell count and subsequently detect and classify a number of cell types, which can ultimately be utilized for diagnostic purposes. Moreover, AI is capable of identifying genetic mutations phenotypically. This pipeline has the potential to offer an accurate and rapid preliminary analysis of the bone marrow in the clinical routine. However, the intrinsic complexity of hematological diseases presents several challenges for the automatic morphological assessment. To ensure general applicability across multiple medical centers and to deliver high accuracy on prospective clinical data, AI models would require highly heterogeneous training datasets. This review presents a systematic analysis of models for cell classification and detection of hematological malignancies published in the last 5 years (2019–2024). It provides insight into the challenges and opportunities of these DL‐assisted tasks.Keywords
This publication has 90 references indexed in Scilit:
- RUNX1 mutations in cytogenetically normal acute myeloid leukemia are associated with a poor prognosis and up-regulation of lymphoid genesHaematologica, 2012
- Implications of discrepancy in morphologic diagnosis of myelodysplastic syndrome between referral and tertiary care centersBlood, 2011
- Measurement uncertainty in manual differential leukocyte countingClinical Chemistry and Laboratory Medicine (CCLM), 2009
- ICSH guidelines for the standardization of bone marrow specimens and reportsInternational Journal of Laboratory Hematology, 2008
- Performance Evaluation of the CellaVision DM96 SystemAmerican Journal of Clinical Pathology, 2005
- The World Health Organization (WHO) classification of the myeloid neoplasmsBlood, 2002
- The molecular biology of chronic myeloid leukaemia.1996
- The acute promyelocytic leukemia-specific PML-RARα fusion protein inhibits differentiation and promotes survival of myeloid precursor cellsCell, 1993
- Molecular insights into the Philadelphia translocation.1991
- BASOPHIL PRODUCTION IN MYELOPROLIFERATIVE DISORDERS - INCREASES DURING ACUTE BLASTIC TRANSFORMATION OF CHRONIC MYELOID-LEUKEMIA1982